Trials / Sponsors / Innocrin Pharmaceutical
Innocrin Pharmaceutical
Industry · 5 registered clinical trials.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Completed | CYP17 Lyase and Androgen Receptor Inhibitor Treatment With Seviteronel Trial (INO-VT-464-006; NCT02580448) Cancer of the Breast, Breast Cancer, Advanced Breast Cancer | Phase 1 / Phase 2 | 2015-08-01 |
| Completed | Once-daily Oral Seviteronel in Patients With Castration-Resistant Prostate Cancer Progressing on Enzalutamide Prostate Cancer | Phase 2 | 2015-05-01 |
| Completed | A Study to Evaluate Once-Daily Oral VT-464 in Patients With Castration-Resistant Prostate Cancer Castration-resistant Prostate Cancer, CRPC | Phase 1 / Phase 2 | 2014-06-01 |
| Completed | Oral VT-464 in Patients With Castration-Resistant Prostate Cancer Previously Treated With Enzalutamide, Androg Prostate Cancer | Phase 2 | 2014-04-01 |
| Completed | A Study to Evaluate Oral VT-464 in Patients With Castration-Resistant Prostate Cancer Castration-resistant Prostate Cancer, CRPC | Phase 2 | 2011-12-01 |